Reflector welcomes the upcoming launch of the much-discussed initiative.
The EU finally is finally starting a new battle in the war against drug counterfeiting, reports Pharm Exec Europe columnist Reflector.
How will the long-threatened revision of the EU's twenty-year old legislation on animal testing affect the industry?
Reflector ponders the good, the bad and the ugly aspects of the EU's antitrust investigations.
Stephen Rose assesses the fallout of the recent antitrust raids on pharma.
Ton van Lierop, from the cabinet of European Commission vice president Günter Verheugen, talks to Pharm Exec Europe about the EC’s ongoing fight against fake medicines.
As two more countries sign up for the euro, Reflector pierces the New Year mist in Brussels to look at just what a common currency means for European pharma.
With NICE-style drug assessments beginning to take hold in countries outside the UK, François Lucas explores industry and payer perspectives on implementing a 'cost-effective' system.
The regulators are full of good ideas when it comes to new initiatives, but the industry knows better than to expect any real advances. Reflector reports on the EIT and the IMI, the latest proposals struggling to leave the launching pad.
